These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8123638

  • 1. PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation.
    Dentan C, Lesnik P, Chapman MJ, Ninio E.
    Arterioscler Thromb; 1994 Mar; 14(3):353-60. PubMed ID: 8123638
    [Abstract] [Full Text] [Related]

  • 2. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL.
    Tsoukatos DC, Arborati M, Liapikos T, Clay KL, Murphy RC, Chapman MJ, Ninio E.
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3505-12. PubMed ID: 9437199
    [Abstract] [Full Text] [Related]

  • 3. PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme.
    Tselepis AD, Dentan C, Karabina SA, Chapman MJ, Ninio E.
    Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1764-73. PubMed ID: 7583554
    [Abstract] [Full Text] [Related]

  • 4. PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.
    Karabina SA, Elisaf MC, Goudevenos J, Siamopoulos KC, Sideris D, Tselepis AD.
    Atherosclerosis; 1996 Aug 23; 125(1):121-34. PubMed ID: 8831934
    [Abstract] [Full Text] [Related]

  • 5. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
    Tsoukatos DC, Liapikos TA, Tselepis AD, Chapman MJ, Ninio E.
    Biochem J; 2001 Jul 15; 357(Pt 2):457-64. PubMed ID: 11439095
    [Abstract] [Full Text] [Related]

  • 6. Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases.
    Dulioust A, Hilliquin P, Menkes CJ, Benveniste J, Arnoux B.
    Scand J Rheumatol; 1992 Jul 15; 21(4):161-4. PubMed ID: 1529281
    [Abstract] [Full Text] [Related]

  • 7. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated.
    Liapikos TA, Antonopoulou S, Karabina SP, Tsoukatos DC, Demopoulos CA, Tselepis AD.
    Biochim Biophys Acta; 1994 Jun 02; 1212(3):353-60. PubMed ID: 8199206
    [Abstract] [Full Text] [Related]

  • 8. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.
    McCall MR, La Belle M, Forte TM, Krauss RM, Takanami Y, Tribble DL.
    Biochim Biophys Acta; 1999 Jan 29; 1437(1):23-36. PubMed ID: 9931415
    [Abstract] [Full Text] [Related]

  • 9. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.
    Ambrosio G, Oriente A, Napoli C, Palumbo G, Chiariello P, Marone G, Condorelli M, Chiariello M, Triggiani M.
    J Clin Invest; 1994 Jun 29; 93(6):2408-16. PubMed ID: 8200975
    [Abstract] [Full Text] [Related]

  • 10. Biosynthesis of paf-acether. XIV. Paf-acether output in murine peritoneal macrophages is regulated by the level of acetylhydrolase.
    Palmantier R, Dulioust A, Maiza H, Benveniste J, Ninio E.
    Biochem Biophys Res Commun; 1989 Jul 14; 162(1):475-82. PubMed ID: 2751666
    [Abstract] [Full Text] [Related]

  • 11. Tissue factor pathway inhibitor activity associated with LDL is inactivated by cell- and copper-mediated oxidation.
    Lesnik P, Dentan C, Vonica A, Moreau M, Chapman MJ.
    Arterioscler Thromb Vasc Biol; 1995 Aug 14; 15(8):1121-30. PubMed ID: 7627705
    [Abstract] [Full Text] [Related]

  • 12. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA, Elisaf M, Bairaktari E, Tzallas C, Siamopoulos KC, Tselepis AD.
    Eur J Clin Invest; 1997 Jul 14; 27(7):595-602. PubMed ID: 9263748
    [Abstract] [Full Text] [Related]

  • 13. The degradation of platelet-activating factor in the plasma of a patient with familial high density lipoprotein deficiency (Tangier disease).
    Pritchard PH, Chonn A, Yeung CC.
    Blood; 1985 Dec 14; 66(6):1476-8. PubMed ID: 4063532
    [Abstract] [Full Text] [Related]

  • 14. Glycosylation enhances oxygen radical-induced modifications and decreases acetylhydrolase activity of human low density lipoprotein.
    Napoli C, Triggiani M, Palumbo G, Condorelli M, Chiariello M, Ambrosio G.
    Basic Res Cardiol; 1997 Apr 14; 92(2):96-105. PubMed ID: 9166989
    [Abstract] [Full Text] [Related]

  • 15. All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase.
    Lee C, Sigari F, Segrado T, Hörkkö S, Hama S, Subbaiah PV, Miwa M, Navab M, Witztum JL, Reaven PD.
    Arterioscler Thromb Vasc Biol; 1999 Jun 14; 19(6):1437-46. PubMed ID: 10364074
    [Abstract] [Full Text] [Related]

  • 16. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma.
    Stremler KE, Stafforini DM, Prescott SM, Zimmerman GA, McIntyre TM.
    J Biol Chem; 1989 Apr 05; 264(10):5331-4. PubMed ID: 2494162
    [Abstract] [Full Text] [Related]

  • 17. Human platelets release a paf-acether: acetylhydrolase similar to that in plasma.
    Korth R, Bidault J, Palmantier R, Benveniste J, Ninio E.
    Lipids; 1993 Mar 05; 28(3):193-9. PubMed ID: 8464350
    [Abstract] [Full Text] [Related]

  • 18. Enhanced association of platelet-activating factor acetylhydrolase with lipoprotein (a) in comparison with low density lipoprotein.
    Blencowe C, Hermetter A, Kostner GM, Deigner HP.
    J Biol Chem; 1995 Dec 29; 270(52):31151-7. PubMed ID: 8537378
    [Abstract] [Full Text] [Related]

  • 19. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein.
    Stafforini DM, Tjoelker LW, McCormick SP, Vaitkus D, McIntyre TM, Gray PW, Young SG, Prescott SM.
    J Biol Chem; 1999 Mar 12; 274(11):7018-24. PubMed ID: 10066756
    [Abstract] [Full Text] [Related]

  • 20. Liver cells secrete the plasma form of platelet-activating factor acetylhydrolase.
    Tarbet EB, Stafforini DM, Elstad MR, Zimmerman GA, McIntyre TM, Prescott SM.
    J Biol Chem; 1991 Sep 05; 266(25):16667-73. PubMed ID: 1653245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.